A2a Pharmaceuticals

AI-driven pharmaceutical company developing novel drug alternatives for life-threatening diseases

placeNew York City, New York, United States calendar_todayFounded 2016 groups4 employees language a2apharma.com

Registered entities

Innovation

5 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 206 times.

YearFilings
20212
20223
20234
20242
20254
20261

Investor mix

2 investors on record; lead investors include IndieBio.

Investor typeCountShare
Venture capital150%
Accelerator & incubator150%
Coming soon